In the present study, we focused on the ANXA10 gene expression and in patient cohort 1, we found a 3.2-fold higher ANXA10 expression in tumours without concomitant CIS compared to tumours with concomitant CIS (P=0.000002, t-test). The gene discussed is ANXA10; the disease is in situ carcinoma.